Streamlined Processes. Faster Approval.

In this new video, we share how our integrated teams’ combined expertise in clinical trials and manufacturing simplify the drug development process, empowering you to bring innovative therapies to market faster and, ultimately, improve patient outcomes.

Watch now to learn how our cohesive approach minimizes delays, reduces costs, and enhances collaboration.

Start watching!

Looking for drug development and manufacturing services? Speak with one of our experts today.

Related resources that may interest you:

• Webpage: Pharmaceutical Contract Manufacturing Services
• eBook: Advantages of Conducting Early-Phase Clinical Research in Canada
• Webinar: Overcoming Challenges in Manufacturing for Clinical Trials

Altasciences’ Commitment to Supporting Pharma and Biotech With Comprehensive Bioanalytical Services

We have been your trusted drug development research partner for over 30 years. We are committed to providing world-class bioanalytical services in support of the preclinical and clinical studies conducted at our cutting-edge facilities, as well as extensive standalone solutions to meet your diverse needs. Our flexible bioanalytical services from discovery to Phase IV empower our clients across every phase of research.

We recently launched the Unveiling the Invisible video campaign to showcase how our bioanalytical solutions provide critical insights that unveil the invisible and drive the creation of your innovative therapies.

RELATED RESOURCES

Our bioanalytical team excels in comprehensive bioanalytical services, including assay and method development, molecular biology, mass spectrometry, ligand binding assays, immunogenicity testing, biomarker analysis, flow cytometry services, and more, to support your journey from discovery through Phase IV.

Below are some resources that highlight our extensive knowledge, and wealth of bioanalytical experience.

• The Altascientist Issue 41: Immunomodulation Assessments for Clinical Trials—Sophisticated Bioanalytical Approaches to Support Complex Modalities
• eBook: Key Considerations for Nonclinical AAV Gene Therapy Development
• eBook: Key Biomarkers of Immunomodulation
• Scientific Research Article: A Novel Hybridization LC-MS/MS Methodology for Quantification of siRNA
• Scientific Research Article: A Validated Capillary Microsampling LC-MS Method for Quantification of ASOs in Mouse Serum
• Scientific Research Article: Microsampling in Pediatric Studies

In this issue of The Altascientist, we explore the current and future development of GLP-1 receptor agonists (GLP-1 RAs), and the complexities involved in the early phases.

Topics covered include preclinical models, bioanalytical assays, clinical study design, manufacturing, and the expanding applications of GLP-1 drugs in treating various health conditions. Exclusive case studies are also presented.

Questions about your drug development program? Speak with one of our experts.

• Webinar: The Golden Era of GLP-1 Drugs
• Blog: Five Promising Treatment Areas in Early-Phase Drug Development
• Webpage: Our Comprehensive Drug Development Solutions

In this new video, our clinical and manufacturing experts share how their teams collaborate and tailor solutions to meet your unique needs. They highlight real examples of going above and beyond by implementing innovative strategies to ensure your projects stay on track.

Start watching!

Looking for a more seamless drug development and manufacturing experience? Speak with one of our experts today.

Related resources that may interest you:

• Video: Nine Strategic Locations to Accelerate Study Timelines
• eBook: Maximizing Drug Formulation for First-in-Human Trials
• Webpage: Pharmaceutical Contract Manufacturing Services
• Podcast: Key Considerations as You Move From Discovery to Preclinical to Clinical

Fundamental Techniques for Optimal Bioavailability

Analytical testing of active pharmaceutical ingredients (APIs) is critical to ensuring their proper absorption and therapeutic effect. This document examines various analytical techniques that support pharmaceutical product development, with a focus on bioavailability. Methods for API characterization, solubility and dissolution testing, and formulation approaches to maximize bioavailability are discussed.

READ IT HERE

Altasciences provides contract HPLC/UPLC method development and validation, stability testing, as well as testing of raw materials, in-process, and finished products for your drug development programs. We take pride in developing, qualifying, and validating robust and rugged analytical procedures to ensure the quality of your products and meet the requirements of regulatory agencies worldwide.

Discover our comprehensive suite of drug development and manufacturing services.

​​Related resources that may interest you:

• Podcast: Ensuring the Successful Manufacturing of Your Clinical Trial Supply
• eBook: Nanomilling for Enhanced Solubility and Bioavailability
• Infographic: Choosing the Optimal Dosage Form for Your Molecule